[Problems of differentiated thymoleptic therapy in phasic depressions].
D000293:Adolescent; D000328:Adult; D000639:Amitriptyline / Q000627:therapeutic use; D000873:Anthracenes / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001392:Azocines / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D001572:Benzofurans / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D002997:Clomipramine / Q000627:therapeutic use; D003527:Cyclothymic Disorder / Q000188:drug therapy*; D003863:Depression / Q000188:drug therapy*; D003984:Dibenzazepines / Q000627:therapeutic use; D004123:Dimethylamines / Q000627:therapeutic use; D004308:Dothiepin / Q000627:therapeutic use; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008744:Methylamines / Q000627:therapeutic use; D008875:Middle Aged; D010554:Personality Disorders / Q000188:drug therapy*; D011437:Propylamines / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*
D000873:Anthracenes; D000928:Antidepressive Agents; D001392:Azocines; D001565:Benzoates; D001572:Benzofurans; D003984:Dibenzazepines; D004123:Dimethylamines; D008744:Methylamines; D011437:Propylamines; D000639:Amitriptyline; D002997:Clomipramine; D007099:Imipramine; D004308:Dothiepin
Voprosy differentsirovannoĭ timolepticheskoĭ terapii fezno protekaiushchikh depressiĭ